SCHEMBL19600430

SCHEMBL19600430

c1ccc(-c2ccccc2-c2ccc3c(c2)Oc2cccc4c(-c5ccc6ccccc6c5)ccc-3c24)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.45
MAPK1 P28482 1/20 0.45
ATM Q13315 1/20 0.45
GPR84 Q9NQS5 1/20 0.37
GSTP1 P09211 1/20 0.36
S1PR5 Q9H228 7/20 0.36
S1PR4 O95977 6/20 0.36
HSD17B1 P14061 1/20 0.35
HSD17B2 P37059 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
MET P08581 1/20 0.34
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
KMT2A Q03164 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19600420 0.91 KDM4E (0.44) KDM4EMAPK1ATMGPR84HSD17B1
SCHEMBL19600405 0.91 KDM4E (0.49) KDM4EMAPK1ATMHDAC8ALDH1A1
SCHEMBL16376392 0.90 KDM4E (0.47) KDM4EMAPK1ATMHDAC8ALDH1A1
SCHEMBL17167454 0.88 MAPK1 (0.50) KDM4EMAPK1ATMGPR84GSTP1
SCHEMBL15856983 0.88 MAPK1 (0.53) KDM4EMAPK1ATMGPR84GSTP1
SCHEMBL26164479 0.88 HSD17B10 (0.39) KDM4EMAPK1ATMGPR84GSTP1
SCHEMBL26164499 0.88 HSD17B10 (0.39) KDM4EMAPK1ATMGPR84GSTP1
SCHEMBL16558311 0.88 MAPK1 (0.54) KDM4EMAPK1ATMGPR84GSTP1
SCHEMBL16558315 0.87 MAPK1 (0.56) KDM4EMAPK1ATMGPR84GSTP1
SCHEMBL19600402 0.87 KDM4E (0.47) KDM4EMAPK1ATMGPR84HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10573825-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-25 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10573825-B2 Compound and organic light-emitting device including the same CRY1, CRY2, AOX1 KDM4E 2074/4885MAPK1 2174/4885ATM 2475/4885
US-20170331051-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, AOX1 KDM4E 2074/4885MAPK1 2174/4885ATM 2475/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.